Metropolis Healthcare

1,572.80
-11.75
(-0.74%)
Market Cap
8,065.50 Cr
EPS
24.95
PE Ratio
53.44
Dividend Yield
0.25 %
52 Week High
2,318.30
52 Week Low
1,527.60
PB Ratio
6.87
Debt to Equity
0.22
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from14 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy+64.29 %
+64.29 %
Hold+7.14 %
+7.14 %
Sell+28.57 %
+28.57 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
2,499.15
#1 20,890.83
50.13
#1 2,295.80
11.52
#1 362
19.34
44.26
1,015.00
10,417.58
72.42
568.60
20.11
120
35.77
46.88
698.35
3,700.80
42.34
581.30
8.63
70
29.25
41.46
815.00
2,631.62
34.57
636.40
25.65
57
49.23
57.29
1,677.00
1,439.32
29.87
86.70
25.47
32
58.82
41.39
242.12
770.20
#1 7.43
1,436.10
35.04
6
-1,081.25
43.66
350.00
248.47
21.80
63.00
#1 248.07
7
133.33
69.90
85.23
87.69
109.40
13.60
-8.11
-3
#1 142.86
58.15
122.55
85.40
66.60
36.90
6.34
1
0.00
45.73
1,572.80
#3 8,065.50
#7 53.44
#3 1,216.80
#9 4.59
#2 129
#8 15.38
37.27
Growth Rate
Revenue Growth
4.59 %
Net Income Growth
-10.39 %
Cash Flow Change
6.87 %
ROE
-19.21 %
ROCE
-13.10 %
EBITDA Margin (Avg.)
-8.13 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
178
198
193
203
205
225
225
210
146
291
279
294
346
308
296
312
283
305
292
284
280
310
293
334
316
353
325
Expenses
132
146
142
145
156
161
159
173
131
198
188
195
224
212
218
231
211
221
215
212
214
234
226
251
235
260
251
EBITDA
46
53
51
58
49
64
66
37
15
94
90
99
122
96
78
81
72
83
77
72
66
76
67
83
81
93
75
Operating Profit %
25 %
25 %
26 %
28 %
24 %
28 %
29 %
16 %
8 %
32 %
32 %
33 %
31 %
30 %
26 %
24 %
24 %
26 %
25 %
25 %
23 %
24 %
22 %
24 %
25 %
26 %
22 %
Depreciation
5
5
5
5
8
9
11
11
10
11
11
14
13
15
17
18
21
22
23
23
21
22
25
26
26
27
28
Interest
0
0
0
0
2
2
2
2
2
2
2
3
6
3
5
6
8
7
6
6
6
6
5
6
5
5
5
Profit Before Tax
42
48
46
52
39
53
53
23
4
81
78
82
103
78
56
57
43
55
48
42
39
48
37
51
51
61
42
Tax
14
18
14
17
12
10
11
8
1
21
19
20
28
19
15
16
9
14
12
8
10
13
10
14
13
15
11
Net Profit
27
30
31
35
27
43
42
16
3
61
59
61
75
58
41
40
34
41
36
34
29
36
27
37
38
47
32
EPS in ₹
4.83
6.14
6.26
6.87
5.34
8.57
8.38
3.09
0.57
11.88
11.50
12.05
14.65
11.39
8.02
7.81
6.53
7.88
6.99
6.51
5.62
6.92
5.30
7.11
7.41
9.08
6.12

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
Total Assets
530
553
752
1,004
1,530
1,502
1,555
Fixed Assets
207
213
296
343
1,059
1,121
1,177
Current Assets
300
305
397
609
393
303
316
Capital Work in Progress
0
6
3
0
6
20
0
Investments
102
33
14
10
16
15
55
Other Assets
221
301
439
651
450
347
323
Total Liabilities
530
553
752
1,004
1,530
1,502
1,555
Current Liabilities
91
125
170
204
302
265
246
Non Current Liabilities
11
8
58
92
341
246
210
Total Equity
429
420
525
708
888
991
1,099
Reserve & Surplus
405
409
513
696
876
978
1,086
Share Capital
10
10
10
10
10
10
10

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
4
14
-1
18
8
56
279
-321
3
-6
Investing Activities
-56
96
-86
1
36
-104
63
-736
48
-89
Operating Activities
70
91
102
104
90
215
249
253
247
264
Financing Activities
-10
-174
-17
-87
-118
-55
-33
163
-292
-181

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
50.38 %
50.37 %
50.33 %
49.50 %
49.79 %
49.79 %
49.76 %
49.76 %
49.75 %
49.75 %
49.74 %
49.74 %
49.67 %
49.62 %
49.43 %
49.40 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
24.29 %
0.00 %
18.90 %
18.25 %
18.56 %
16.73 %
DIIs
15.34 %
14.22 %
11.77 %
10.63 %
15.32 %
13.85 %
11.88 %
13.30 %
13.64 %
14.47 %
16.86 %
20.28 %
24.86 %
27.43 %
28.02 %
30.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
3.95 %
3.98 %
4.24 %
6.50 %
9.14 %
9.26 %
9.45 %
9.73 %
8.53 %
8.15 %
7.78 %
6.63 %
5.24 %
4.07 %
3.54 %
3.34 %
Others
30.33 %
31.43 %
33.66 %
33.37 %
25.75 %
27.10 %
28.91 %
27.21 %
28.08 %
27.62 %
1.32 %
23.35 %
1.33 %
0.63 %
0.45 %
0.53 %
No of Share Holders
30,679
33,527
43,552
64,168
79,895
86,404
90,090
91,452
84,269
89,692
86,249
79,878
68,283
58,108
51,852
48,572

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 13.26 8 8 8 8 4 0.00
Dividend Yield (%) 0.00 0.00 0.00 1.03 0.36 0.39 0.67 0.46 0.25 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Updates on Acquisition5 days ago
Announcement under Regulation 30 (LODR)-Change in Directorate10 days ago
Announcement under Regulation 30 (LODR)-Change in Management10 days ago
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday March 17 202510 days ago
Grant Of Restrictive Stock Units Under The Metropolis - Restrictive Stock Unit Plan 202010 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 03, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 03, 2025
Announcement under Regulation 30 (LODR)-AcquisitionMar 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 24, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 18, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 13, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 11, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 10, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotFeb 10, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionFeb 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 05, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 04, 2025
Integrated Filing (Financial)Feb 04, 2025
Board Meeting Outcome for The Meeting Held Today (February 04 2025)Feb 04, 2025
Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024Feb 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 04, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJan 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 29, 2025
Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2024Jan 29, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 11, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2025
Change In The Name Of The Registrar And Transfer Agent Of The CompanyJan 06, 2025
Business Update For Q3FY25Jan 06, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 03, 2025
Closure of Trading WindowDec 31, 2024
Transcript Of Investor Conference CallDec 16, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeDec 10, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationDec 09, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 09, 2024
Announcement under Regulation 30 (LODR)-Preferential IssueDec 09, 2024
Announcement under Regulation 30 (LODR)-AcquisitionDec 09, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday, December 09, 2024Dec 09, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 05, 2024
Board Meeting Intimation for Considering The Issuance Of Equity Shares Of The Company On A Preferential BasisDec 04, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementNov 28, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 16, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 11, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 09, 2024
Amendment To The Code Of Fair Disclosure Of Unpublished Price Sensitive Information And Policy For Legitimate PurposeNov 08, 2024

Technical Indicators

RSI(14)
Neutral
37.27
ATR(14)
Less Volatile
56.63
STOCH(9,6)
Neutral
31.84
STOCH RSI(14)
Oversold
19.05
MACD(12,26)
Bullish
4.08
ADX(14)
Weak Trend
22.44
UO(9)
Bearish
43.88
ROC(12)
Downtrend And Accelerating
-4.75
WillR(14)
Neutral
-69.17

About Metropolis Healthcare

Metropolis Healthcare Limited is an Indian diagnostic services company operating across India and Africa. Founded in 1980 as a pathology partnership, it has evolved into a public company offering a wide range of clinical laboratory tests and profiles. The company operates through a hub and spoke model with 115 clinical laboratories, including a global reference laboratory in Mumbai, regional reference laboratories, satellite laboratories, and express laboratories. Metropolis provides services to both B2B and B2C markets, covering 197 cities in India and has operations in several African countries. The company offers approximately 3,487 clinical laboratory tests and 530 profiles, and has expanded its network through acquisitions and mergers. Metropolis is known for its quality diagnostics and has received awards for customer service and healthcare excellence.
Listing Date
15 Apr, 2019(5 Years, 41 days)
Chairperson Name